Canaan X L.P. Next Cure, Inc. (NXTC) insider trading activity

NXTC Quotes by TradingView

Canaan X L.P. is > 10% Shareholder of NextCure, Inc.. Currently has a direct ownership of 2.25 Million shares of NXTC, which is worth approximately $3.47 Million. The most recent transaction as insider was on May 13, 2019, when has been sold 2,204,442 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.25M
0% 3M change
0% 12M change
Total Value Held $3.47 Million

CANAAN X L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 13 2019
BUY
Conversion of derivative security
-
2,204,442 Added 50.0%
2,204,442 Common Stock
May 13 2019
BUY
Open market or private purchase
$750,000 $15.0 p/Share
50,000 Added 2.17%
2,254,442 Common Stock

Also insider at

ITRM
Iterum Therapeutics plc Healthcare
Director
PTGX
Protagonist Therapeutics, Inc Healthcare
> 10% Shareholder
IDYA
IDEAYA Biosciences, Inc. Healthcare
> 10% Shareholder
ASTR
Astra Space, Inc. Industrials
> 10% Shareholder
CXL

Canaan X L.P.

> 10% Shareholder
Westport, CT

Track Institutional and Insider Activities on NXTC

Follow NextCure, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NXTC shares.

Notify only if

Insider Trading

Get notified when an Next Cure, Inc. insider buys or sells NXTC shares.

Notify only if

News

Receive news related to NextCure, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NXTC